Genentech Provides Update On Phase Iii Study Of Avastin In Men With Late Stage Prostate Cancer Source: Medical News Today Sunday 14th March, 2010
Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the topline results of a Phase III trial led by the U.S. ...
